MARIBETH EVANS: Open Payments
NPI 1003476888 · OGDENSBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 29 payments from 10 companies in 2025. Trend: 2023 $536 · 2024 $1,310 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $291 |
| Janssen Pharmaceuticals, Inc | 3 | $174 |
| Alkermes, Inc. | 4 | $150 |
| ABBVIE INC. | 6 | $145 |
| Braeburn Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Corium, LLC | 1 | $17 |
| Luye Pharma (USA) Ltd. | 1 | $14 |
Products named: INVEGA SUSTENNA, VRAYLAR, ABILIFY ASIMTUFII, LYBALVI, BRIXADI, REXULTI, UZEDY, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
